Safe and Effective Design of Bioequivalence Study of 400 mg of Imatinib in Normal Healthy Volunteers under Both Fasting and Fed Conditions: A Biopharma Services Inc. Perspective
Safe and Effective Design of Bioequivalence Study of 400 mg of Imatinib in Normal Healthy Volunteers under Both Fasting and Fed Conditions: A Biopharma Services Inc. Perspective PRESENTED TO: BioPharma Services Inc. PRESENTED BY: J. He, N. Gharavi, H. Somasundaram, U....
Nonparametric Superposition to Predict Ropinirole Pharmacokinetics Data at Steady-state using Single-dose Data
Nonparametric Superposition to Predict Ropinirole Pharmacokinetics Data at Steady-state using Single-dose Data PRESENTED TO: BioPharma Services Inc., Toronto, ON, CanadaPRESENTED BY: Z. Tayab, F. Trabelsi, J. He PURPOSE The current EMA bioequivalence guideline states...
LC-MS/MS Method of Fingolimod in Human Whole Blood: Is Sensitivity and Required Blood Volume an Issue?
LC-MS/MS Method of Fingolimod in Human Whole Blood: Is Sensitivity and Required Blood Volume an Issue? PRESENTED TO: BioPharma Services Inc., Toronto, ON, CanadaPRESENTED BY: Juan He, Priscila Pequeno, Yu Ding, Rabiya Chandani, Negar Gharavi, and Fethi Trabelsi...
Large-Scale Retrospective Evaluation of Regulated LC-MS Bioanalysis Projects Using Different Total Error Approaches
Large-Scale Retrospective Evaluation of Regulated LC-MS Bioanalysis Projects Using Different Total Error Approaches PRESENTED TO: (a) BioPharma Services Inc., Toronto, ON, Canada; (b) Cetre Universitaire Régional d’Interface, Université Sidi Mohamed Ben Abdallah,...
Recent Comments